Huge new today, this AM was PGNX buyout news. I n
Post# of 148185
It you are tracking the corp. IMO, they have nothing but Leronlimabs royalties.
Their market cap was around $500m. The buyer had a market cap of around twice as much.
In an all shares transaction of 4 to 1.
Interestingly that bio professionals on other boards (non CYDY) are wondering what PGNX had of a value for LNTH.
LNTH dipped 25% today. I loaded some on that end of Leronlimab as well. If the BO doesn't complete, LNTH should retain it original value + get an $18m in penalty. But I'm sure they have secured it, and will make it happen.
I don't want to start a conspirancy but IMO:
From CYDY perspective, that's all they were after and they had to take it out, as they couldn't take CYDY. PGNX CEO had difficulties and he sold for a cheap price, if you were following lawsuits, and so on.
WE ARE SITTING ON A GOLD MINE
All IMO
GTLA